Cargando…
Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review
Post-stroke depression (PSD) is a biopsychosocial disorder that affects individuals who have suffered a stroke at any point. PSD has a 20 to 60 percent reported prevalence among stroke survivors. Its effects are usually adverse, can lead to disability, and may increase mortality if not managed or tr...
Autores principales: | Frank, Dmitry, Gruenbaum, Benjamin F., Zlotnik, Alexander, Semyonov, Michael, Frenkel, Amit, Boyko, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738261/ https://www.ncbi.nlm.nih.gov/pubmed/36499434 http://dx.doi.org/10.3390/ijms232315114 |
Ejemplares similares
-
The Development of Novel Drug Treatments for Stroke Patients: A Review
por: Frank, Dmitry, et al.
Publicado: (2022) -
Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depression
por: Gruenbaum, Benjamin F., et al.
Publicado: (2020) -
Glutamate Efflux across the Blood–Brain Barrier: New Perspectives on the Relationship between Depression and the Glutamatergic System
por: Gruenbaum, Benjamin Fredrick, et al.
Publicado: (2022) -
Glutamate Neurotoxicity and Destruction of the Blood–Brain Barrier: Key Pathways for the Development of Neuropsychiatric Consequences of TBI and Their Potential Treatment Strategies
por: Gruenbaum, Benjamin F., et al.
Publicado: (2022) -
Traumatic brain injury-induced submissive behavior in rats: link to depression and anxiety
por: Boyko, Matthew, et al.
Publicado: (2022)